Medications That Can Increase Lactate Levels
Metformin is the most well-documented medication that can increase lactate levels, particularly in patients with renal impairment, hypoxic states, or other conditions that impair lactate clearance. 1, 2
Primary Medications That Increase Lactate
1. Metformin
- Mechanism: Inhibits mitochondrial respiration predominantly in the liver, leading to increased plasma lactate levels in a concentration-dependent manner 3
- Risk factors for lactic acidosis with metformin use:
2. Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Particularly older agents like stavudine, didanosine, and zidovudine
- Mechanism: Mitochondrial toxicity leading to impaired oxidative phosphorylation 5
Other Medications That May Increase Lactate
3. SGLT2 Inhibitors
- May indirectly increase lactate through euglycemic diabetic ketoacidosis, particularly in patients with poor food intake 1
- Examples: empagliflozin, canagliflozin, dapagliflozin
4. Beta-adrenergic agonists
- Increase glycolysis and lactate production
- Examples: epinephrine, albuterol, terbutaline
5. Propofol
- Can cause propofol infusion syndrome with lactic acidosis in high doses or prolonged use
6. Linezolid
- Inhibits mitochondrial protein synthesis, potentially leading to lactic acidosis with prolonged use
7. Alcohols and glycols
- Ethanol, methanol, ethylene glycol
- Metabolized to compounds that increase the anion gap and lactate
Clinical Management Considerations
Metformin Use Based on Renal Function
- eGFR ≥45 mL/min/1.73 m²: Safe to continue metformin 1
- eGFR 30-44 mL/min/1.73 m²: Dose reduction recommended; use with caution 1
- eGFR <30 mL/min/1.73 m²: Metformin is contraindicated 1, 2
Temporary Discontinuation of Metformin
Metformin should be temporarily discontinued in:
- Patients undergoing procedures with iodinated contrast 2
- Situations with risk of acute kidney injury 1
- Acute illness, surgery, or other conditions causing hypoxemia 1
- Severe infection or sepsis 1
Monitoring Recommendations
- Regular monitoring of renal function in all patients on metformin 2
- Consider lactate level monitoring in high-risk patients (elderly, multiple comorbidities) 1
- More frequent monitoring in patients with eGFR 30-45 mL/min/1.73 m² 1
Important Clinical Pitfalls
Overestimation of risk: Despite concerns, the actual incidence of metformin-associated lactic acidosis is very low (<10 cases per 100,000 patient-years) 3
Misattribution: Many cases of lactic acidosis in metformin users are due to underlying conditions rather than metformin itself 6
Inappropriate discontinuation: Discontinuing metformin unnecessarily may deprive patients of its cardiovascular and mortality benefits 1
Failure to recognize early signs: Symptoms of lactic acidosis (malaise, myalgias, respiratory distress, abdominal pain, somnolence) can be subtle and nonspecific 2
Inadequate dose adjustment: Failure to adjust metformin dose in patients with declining renal function increases risk 4